4 completed, 1 not yet recruiting, 1 recruiting. 6 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 4, Not yet recruiting 1, Recruiting 1 |
| Phase 1 | 1 | Completed 1 |
Follow gadopiclenol: new trials by email Literature Review of gadopiclenol trials Research Report on gadopiclenol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Screening for Brain Metastases gadopiclenol (contrast agent), standard contrast agent - Lung Cancer Stage IV, Melanoma Stage IV | Phase 2 | Not yet recruiting | University of Zurich | 180 | 2026-09-01 | 2026-03-25 |
| Study of 18F-FFNP Breast PET/MRI 18F-fluorofuranylnorprogesterone, Positron Emissions Tomography / Magnetic Resonance Imaging, Anastrozole - Breast Cancer | Phase 2 | Recruiting | University of Wisconsin, Madison | 53 | 2024-09-25 | 2026-08-31 |
| Gadopiclenol Pharmacokinetics, Safety and Efficacy in Children < 2 Years of Age Gadopiclenol - Central Nervous System Diseases, Pediatric Disorder | Phase 2 | Completed | Guerbet | 36 | 2022-09-21 | 2025-10-28 |
| Pharmacokinetics, Safety and Efficacy of P03277 in Pediatric Patients Undergoing Central Nervous System Contrast-enhanced MRI P03277 - Central Nervous System Indication, Pediatric Patients | Phase 2 | Completed | Guerbet | 80 | 2018-11-06 | 2022-06-01 |
| P03277 Dose Finding Study in Central Nervous System (CNS) Magnetic Resonance Imaging (MRI) P03277, Gadobenate dimeglumine, MRI - CNS Lesion, Blood Brain Barrier Defect | Phase 2 | Completed | Guerbet | 312 | 2016-06-01 | 2021-10-25 |
| Pharmacokinetics, Pharmacodynamics Profile and Tolerance of P03277 in Healthy Subjects and Patients With Brain Lesions P03277, Placebo - Healthy Volunteers, Brain Lesion | Phase 1 / Phase 2 | Completed | Guerbet | 142 | 2013-11-25 | 2021-05-14 |
Breast Neoplasms (1) · Central Nervous System Diseases (1) · Lung Neoplasms (1) · Melanoma (1)
Guerbet (4) · University of Wisconsin, Madison (1) · University of Zurich (1)
Hungary (3) · Poland (3) · United States (3) · Belgium (2) · Bulgaria (1) · Czechia (1) · Italy (1) · Mexico (1) · Slovakia (1) · South Korea (1) · Switzerland (1) · Ukraine (1)
Amy M Fowler, MD, PHD (1) · Donna R Roberts, MD (1) · Wouter Haazen, MD (1)
PMID 30870257, PMID 31917762, PMID 35318970
2018 (1), R01CA272571 (1)